Tim Watkins's Insider Trades & SAST Disclosures

Tim Watkins's most recent trade in Contineum Therapeutics Inc. - Ordinary Shares - Class A was a trade of 260,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 28, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Contineum Therapeutics Inc...
Tim Watkins CMO & Head of Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2025 260,000 260,000 - - Stock Option (right to buy)
Contineum Therapeutics Inc...
Tim Watkins CMO & Head of Development Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2025 26,000 26,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades